HLN Haleon plc

NYSE


$ 9.28 $ 0.09 (0.98 %)    

Friday, 31-Oct-2025 15:59:56 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 9.27
$ 9.22
$ 8.99 x 200
$ 9.41 x 33
$ 9.19 - $ 9.32
$ 8.70 - $ 11.35
9,969,979
na
84.21B
$ 0.11
$ 46.64
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 salesforce-strengthens-ai-offerings-via-vonage-haleon-tie-ups

Salesforce (NYSE: CRM) partners with Vonage and Haleon to expand AI, Cloud, and 5G innovation using Data Cloud and Agentforce s...

Core News & Articles

Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the...

 emma-walmsley-to-step-down-as-gsk-ceo-after-nine-years-luke-miels-to-lead-starting-january-2026

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Bo...

 barclays-downgrades-haleon-to-equal-weight

Barclays analyst Warren Ackerman downgrades Haleon (NYSE:HLN) from Overweight to Equal-Weight.

Core News & Articles

https://www.wsj.com/health/healthcare/rfk-jr-hhs-to-link-autism-to-tylenol-use-in-pregnancy-and

 kkr-outbids-competitors-to-secure-29-billion-karo-healthcare-takeover

KKR is closing in on a $2.9B takeover of Karo Healthcare after outbidding rivals, reinforcing its aggressive push into European...

 pfizer-offloads-its-last-7-stake-in-consumer-health-haleon-for-over-3-billion

Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...

Core News & Articles

- Reuters Citing Citigroup Global Market

 sensodyne-toothpaste-maker-haleon-expects-profit-to-be-weighted-towards-second-half-of-2025

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains wei...

 dr-reddys-laboratories-q3-earnings-double-digit-growth-aided-by-newly-acquired-nicotine-replacement-business

Dr. Reddy's Q3 FY2025 revenue reached $977 million, up 16%, with $165M net income. Growth fueled by NRT portfolio and globa...

Core News & Articles

- Reuters

 what-to-expect-when-pfizer-outlines-its-2025-financial-outlook-on-tuesday

Pfizer's 2025 guidance to be revealed Tuesday. Goldman Sachs predicts $64.9 billion revenue and EPS of $3.13, supported by ...

 haleon-selects-vistar-media-as-preferred-global-partner-for-programmatic-out-of-home-advertising-across-all-key-markets

Haleon, a global leader in consumer healthcare, has chosen Vistar Media, the leading global provider of technology solutions fo...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION